Short answer
SI-BONE, Inc. (SIBN) filed an 8-K current report with the SEC on August 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). No substantive Item 2.02 earnings information in the provided text.
SI-BONE, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- No substantive Item 2.02 earnings information in the provided text
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $56.0M, up 15.2%, with U.S. procedure volume growth of 14.9%
- Adjusted EBITDA $2.8M versus $1.0M, while net loss narrowed to $4.1M from $6.2M
- Cash and equivalents $145.9M, up $1.3M sequentially, supporting continued product commercialization
- Active U.S. physicians rose 19% to 1,715, expanding the platform’s adoption base
- 2026 revenue guidance raised to $231M-$233M; adjusted EBITDA remains positive and expense growth target lowered to 12%
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SI-BONE, Inc. 8-K filings
Get the next SIBN 8-K as it lands
Follow SIBN for push alerts, or ask the research agent what this filing means.